Entest Group Inc, based in La Mesa, CA, is a biotechnology company focused on developing innovative treatments for cancer and autoimmune disorders. Their primary program involves developing modulators of the immune checkpoint NR2F6, with a strong patent portfolio in place for this technology.
The company's diverse pre-clinical pipeline includes cell therapies, RNA vaccines, RNA and DNA therapeutics, and small molecule drugs, all protected by multiple granted and pending patents. Entest Group Inc is dedicated to advancing novel technologies through pre-clinical and Phase I II clinical trials to improve the quality of life for patients facing these challenging health conditions.
Generated from the website